STEVEN CARDENAS: Open Payments
NPI 1376212050 · OAKLAND PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,111 in 93 payments from 20 companies in 2025. Trend: 2023 $1,221 · 2024 $2,841 · 2025 $2,111
Food & beverage: $2,111
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 31 | $787 |
| ViiV Healthcare Company | 24 | $565 |
| Novo Nordisk Inc | 10 | $189 |
| Theratechnologies Inc. | 6 | $150 |
| Verity Pharmaceuticals Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $40 |
| EMD Serono, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
Products named: CABENUVA, DOVATO, EGRIFTA, Yeztugo, APRETUDE, Ozempic, Biktarvy, RUKOBIA.
Industry payments across FL — which companies pay providers there.
